首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
【24h】

Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).

机译:亚洲国家肺炎链球菌的大环内酯耐药性和基因型特征:亚洲耐药性病原体监测网络(ANSORP)的研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To characterize mechanisms of macrolide resistance among Streptococcus pneumoniae from 10 Asian countries during 1998-2001. METHODS: Phenotypic and genotypic characterization of the isolates and their resistance mechanisms. RESULTS: Of 555 isolates studied, 216 (38.9%) were susceptible, 10 (1.8%) were intermediate and 329 (59.3%) were resistant to erythromycin. Vietnam had the highest prevalence of erythromycin resistance (88.3%), followed by Taiwan (87.2%), Korea (85.1%), Hong Kong (76.5%) and China (75.6%). Ribosomal methylation encoded by erm(B) was the most common mechanism of erythromycin resistance in China, Taiwan, Sri Lanka and Korea. In Hong Kong, Singapore, Thailand and Malaysia, efflux encoded by mef(A) was the more common in erythromycin-resistant isolates. In most Asian countries except Hong Kong, Malaysia and Singapore, erm(B) was found in >50% of pneumococcal isolates either alone or in combination with mef(A). The level of erythromycin resistance among pneumococcal isolates in most Asian countries except Thailand and India was very high with MIC(90)s of >128 mg/L. Molecular epidemiological studies suggest the horizontal transfer of the erm(B) gene and clonal dissemination of resistant strains in the Asian region. CONCLUSION: Data confirm that macrolide resistance in pneumococci is a serious problem in many Asian countries.
机译:目的:确定1998-2001年间来自10个亚洲国家的肺炎链球菌对大环内酯类药物的耐药机制。方法:分离株的表型和基因型特征及其耐药机制。结果:在研究的555株菌株中,有216株(38.9%)易感,有10株(1.8%)为中度,有329株(59.3%)对红霉素有抗药性。越南对红霉素的耐药率最高(88.3%),其次是台湾(87.2%),韩国(85.1%),香港(76.5%)和中国(75.6%)。 erm(B)编码的核糖体甲基化是中国,台湾,斯里兰卡和韩国对红霉素耐药的最常见机制。在香港,新加坡,泰国和马来西亚,由mef(A)编码的外排在耐红霉素的分离株中更为常见。在除香港,马来西亚和新加坡以外的大多数亚洲国家中,单独或与mef(A)联合使用的肺炎球菌分离株中,> 50%都发现了erm(B)。除泰国和印度外,大多数亚洲国家/地区的肺炎球菌分离株对红霉素的耐药性很高,MIC(90)s> 128 mg / L。分子流行病学研究表明,erm(B)基因的水平转移和亚洲地区耐药菌株的克隆传播。结论:数据证实肺炎球菌对大环内酯类药物的耐药性是许多亚洲国家的严重问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号